The Pharmaceutical Regulatory Process
This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by to...
Αποθηκεύτηκε σε:
Κύριος συγγραφέας: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Βιβλίο |
Γλώσσα: | Αγγλικά |
Έκδοση: |
New York
Informa Healthcare USA Inc.
2021
|
Έκδοση: | 2nd ed. |
Σειρά: | Drugs and The Pharmaceutical Sciences Series
Vol. 185 |
Θέματα: | |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
MARC
LEADER | 00000nam a22000007a 4500 | ||
---|---|---|---|
008 | 211012b ||||| |||| 00| 0 eng d | ||
020 | |a 9780367202842 | ||
082 | |a 344.7304233 |b THE | ||
100 | |a Berry, Ira R. |9 8386 | ||
245 | |a The Pharmaceutical Regulatory Process | ||
250 | |a 2nd ed. | ||
260 | |a New York |b Informa Healthcare USA Inc. |c 2021 | ||
300 | |a x, 469 p. | ||
490 | |a Drugs and The Pharmaceutical Sciences Series |v Vol. 185 | ||
520 | |a This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by top industry professionals, practicing attorneys, and FDA regulators, it includes policies and procedures that pharmaceutical companies need to implement regulatory compliance post-approval. | ||
650 | |a Pharmacy - Law and Legislation - United States |9 9252 | ||
650 | |a Drugs - Law and Legislation | ||
700 | |a Berry, Ira R. |9 8386 | ||
700 | |a Martin, Robert P. |9 9253 | ||
952 | |0 0 |1 0 |2 ddc |4 0 |6 344_730423300000000_THE |7 0 |9 13594 |a 50008178 |b 50008178 |d 2022-06-11 |e PBS |g 2996.25 |l 0 |o 344.7304233 THE |p JP001777 |r 2022-06-11 00:00:00 |v 3995.00 |w 2022-06-11 |y RB | ||
999 | |c 7784 |d 7784 |